About the study.
Genetic testing can be done to see if you were born with the variation in your APOL1 gene that causes genetic FSGS. The study will require a blood test to determine if you have this gene variation. The results of this genetic test may qualify you for a future clinical research study for adults with FSGS.
The test used to determine if you have an APOL1 gene variation is not FDA approved, which means that it is not available outside of a research study and is not intended to drive decisions about your medical care. The FDA and other regulatory agencies have approved this test for research purposes ONLY. As with any genetic test, there is a risk of inaccurate results. Vertex is taking efforts to reduce this risk by testing your blood sample under industry standard processes and guidelines. If you would like more information about this genetic test, please ask your study doctor.
We are currently enrolling adults 18 years or older who have been diagnosed with biopsy-confirmed FSGS to take part in this clinical research study. It may be appropriate for those who meet the following criteria:
- Male or female of African or Caribbean descent
- Diagnosed with FSGS via a kidney biopsy
- Willing and able to comply with the testing requirements
Those who qualify will receive this testing at no cost. If you qualify, you may be compensated for your study-related time and travel. You may also be eligible for travel assistance.